Gerrit Jan Weverling

Authorised Association Consortium — TZ

Immunology and Microbiology · Life Sciences

46h-index7.0kcitations101works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(35), HIV/AIDS drug development and treatment(32), HIV/AIDS Research and Interventions(21), Viral-associated cancers and disorders(9), Cytomegalovirus and herpesvirus research(9)

Publications100 total

Genome‐wide profiling of circulatory microRNAs associated with cognition and dementia
Alzheimer s & Dementia·2022· 17 citedOpen Access
Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults
PLoS ONE·2021· 82 citedOpen Access
Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. Adults
2021· 23 citedOpen Access
Multi-Omics Analysis Reveals MicroRNAs Associated With Cardiometabolic Traits
Frontiers in Genetics·2020· 25 citedOpen Access
Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
Brain·2020· 308 citedOpen Access
Quantification of biological age as a determinant of age-related diseases in the Rotterdam Study: a structural equation modeling approach
European Journal of Epidemiology·2019· 51 citedOpen Access
O1‐05‐01: TRENDS IN INCIDENCE OF DEMENTIA AND ALZHEIMER'S DISEASE: RESULTS OF THE ALZHEIMER COHORTS CONSORTIUM
Alzheimer s & Dementia·2018
<i>In Vitro</i> Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice
Journal of Virology·2017· 53 citedOpen Access
A Downward Trend of the Ratio of Influenza RNA Copy Number to Infectious Viral Titer in Hospitalized Influenza A-Infected Patients
Open Forum Infectious Diseases·2015· 14 citedOpen Access
Transient Humoral Protection against H5N1 Challenge after Seasonal Influenza Vaccination of Humans
PLoS ONE·2014· 12 citedOpen Access
Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species
PLoS ONE·2012· 59 citedOpen Access
The immunogenicity and safety of a single 0.5mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to &lt;36 months: Data from a randomized, Phase III study
Vaccine·2012· 13 cited
Validation of the Rapid Fluorescent Focus Inhibition Test for Rabies Virus-Neutralizing Antibodies in Clinical Samples
Antimicrobial Agents and Chemotherapy·2012· 45 citedOpen Access
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
Vaccine·2011· 101 cited
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
Vaccine·2011· 303 cited
The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4 <sup>+</sup> and CD8 <sup>+</sup> T Cells in Adults
American Journal of Respiratory and Critical Care Medicine·2010· 227 cited
New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets
PLoS ONE·2010· 101 citedOpen Access
Pre‐ and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir
The Journal of Infectious Diseases·2009· 41 citedOpen Access
First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
Vaccine·2008· 137 cited
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: Impact of distinct additional adjuvants
Vaccine·2008· 50 cited
page 1 of 5Next →

Frequent Co-authors

Jaap Goudsmit(18), Joep M. A. Lange(10), Suzanne Jurriaans(7), Peter Reiss(7), Hanneke Schuitemaker(6), Richard M. W. Hoetelmans(5), Jan W. Mulder(5), Wouter Koudstaal(4), Stefan Kostense(4), Maria Grazia Pau(4), Roel A. Coutinho(4), Ferdinand W.N.M. Wit(4), Jan M. Prins(4), J. Klap(3), Jaap Goudsmit(3), Neil Renwick(3), Nicole H. T. M. Dukers–Muijrers(3), Thomas F. Schulz(3), Marijke Roos(3), Remko van Leeuwen(3)